Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03577990 · ClinicalTrials.gov registry record · NA
Technology Coaching Intervention for Black Women With Hypertension
A NA study of Uncontrolled Hypertension, sponsored by University of North Carolina, Charlotte.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT03577990: Completed NA study of Uncontrolled Hypertension, sponsored by University of North Carolina, Charlotte.
NCT03577990 is a NA study of Uncontrolled Hypertension that has completed, run by University of North Carolina, Charlotte. The registered enrollment target is 90 participants, below the 755-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03577990, a NA study of Uncontrolled Hypertension, has completed, sponsored by University of North Carolina, Charlotte.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertension (HTN) is a global problem affecting 972 million adults and an important public health burden since it is the main cause of cardiovascular disease and death, and the second leading cause of disability. Disproportionately affected, Black women have the highest prevalence of HTN in the United States. This research will evaluate potential interventions for possible community-based strategies for controlling HTN using interactive self-care strategies with coaching and technology. We hypothesize that participants who receive the Chronic Disease Self-Management Program (CDSMP) workshop and Interactive Technology Enhanced Coaching (ITEC) will have lower systolic/diastolic blood pressure (BP) and better adherence to antihypertensive medication(s) and lifestyle recommendations (physical activity, diet, and weight management) post intervention compared to participants receiving self-care management alone.
Primary Outcome
To show the change (decrease) in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 9 months.
Conditions Studied
Interventions
- BEHAVIORAL Interactive Technology Enhanced Coaching (ITEC)
- BEHAVIORAL Interactive Technology-No Coaching (IT)
Study Locations (1)
North Carolina
- Churches, Salons, Community Events - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2021-04-16 |
| Phase | NA |
What the finished NCT03577990 record still lists
NCT03577990 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 755-participant average among 10 other Uncontrolled Hypertension trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Uncontrolled Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Interactive Technology Enhanced Coaching (ITEC) is the first listed.
NCT03577990 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03577990 about?
NCT03577990 is a clinical study titled "Technology Coaching Intervention for Black Women With Hypertension". Hypertension (HTN) is a global problem affecting 972 million adults and an important public health burden since it is the main cause of cardiovascular disease and death, and the second leading cause of disability. Disproportionately affected, Black women have the highest prevalence of HTN in the Uni...
What is the current status of trial NCT03577990?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2019-01-28. Estimated completion is 2021-04-16.
What conditions does trial NCT03577990 study?
This clinical trial studies the following conditions: Uncontrolled Hypertension.
What interventions are being tested in trial NCT03577990?
The interventions under investigation include: Interactive Technology Enhanced Coaching (ITEC) (BEHAVIORAL), Interactive Technology-No Coaching (IT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03577990?
This trial is sponsored by University of North Carolina, Charlotte, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03577990 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uncontrolled Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03577990's enrollment target sits among peer trials
90 9th of 10 higher than 2 of 10 other Uncontrolled Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uncontrolled Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
RECRUITING · NA
-
Renal Pelvic Denervation Pilot Trial
RECRUITING · NA
-
Wearable Evaluation of Ambulatory Readings for Blood Pressure
RECRUITING · NA
-
Remote Hypertension Management for Black Patients
RECRUITING · NA
-
Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes.
ACTIVE NOT RECRUITING · NA
-
Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI